Variant report
Variant | esv3339715 |
---|---|
Chromosome Location | chr6:142324459-142326607 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs542602120 | chr6:142324497-142324498 | Weak transcription Enhancers Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs143149189 | chr6:142324517-142324518 | Weak transcription Enhancers Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs151150769 | chr6:142324607-142324608 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs17071344 | chr6:142324609-142324610 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs187240769 | chr6:142324635-142324636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs575899150 | chr6:142324641-142324642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs377230043 | chr6:142324675-142324676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs116642603 | chr6:142324691-142324692 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs114185777 | chr6:142324732-142324733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs200740267 | chr6:142324751-142324752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs528487795 | chr6:142324787-142324788 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540586168 | chr6:142324837-142324838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs34415342 | chr6:142324842-142324843 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs559409057 | chr6:142324860-142324861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs190870968 | chr6:142324862-142324863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs182131958 | chr6:142324876-142324877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs534531328 | chr6:142324891-142324892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs185607652 | chr6:142324918-142324919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs190071069 | chr6:142324937-142324938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs183060938 | chr6:142324981-142324982 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs9389967 | chr6:142324989-142324990 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs9403364 | chr6:142324990-142324991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs373618900 | chr6:142325003-142325004 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs375441019 | chr6:142325022-142325023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs533392373 | chr6:142325047-142325048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs570485129 | chr6:142325050-142325051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs35447421 | chr6:142325194-142325195 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs13198788 | chr6:142325218-142325219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs530640833 | chr6:142325402-142325403 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs534881564 | chr6:142325413-142325414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs188400483 | chr6:142325439-142325440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs193033149 | chr6:142325484-142325485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs546606197 | chr6:142325490-142325491 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs377219750 | chr6:142325509-142325510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs183956493 | chr6:142325534-142325535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs188959750 | chr6:142325569-142325570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs192449999 | chr6:142325617-142325618 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs575913689 | chr6:142325633-142325634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs538502944 | chr6:142325648-142325649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs543898776 | chr6:142325672-142325673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs539983066 | chr6:142325673-142325674 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs183736931 | chr6:142325688-142325689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs188850997 | chr6:142325690-142325691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs111210620 | chr6:142325701-142325702 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs561780213 | chr6:142325713-142325714 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs200443335 | chr6:142325715-142325716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs150333992 | chr6:142325726-142325727 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs369816813 | chr6:142325738-142325739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs201574674 | chr6:142325740-142325741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs144951564 | chr6:142325751-142325752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Gastric cancer | 17908304 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Breast cancer | 21364760 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Prostate cancer | 18632612 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Endocrine pancreatic tumor | 17914106 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:142310800-142334400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr6:142311000-142329000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr6:142312200-142329000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
4 | chr6:142320800-142330200 | Weak transcription | HSMM | muscle |
5 | chr6:142324400-142324600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
6 | chr6:142324400-142324600 | Active TSS | Muscle Satellite Cultured Cells | -- |
7 | chr6:142324400-142324600 | Genic enhancers | K562 | blood |
8 | chr6:142324600-142326200 | Weak transcription | K562 | blood |
9 | chr6:142324600-142335000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
10 | chr6:142326200-142326600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
11 | chr6:142326200-142326800 | Enhancers | K562 | blood |